Article
SITAGLIPTIN MITIGATES SCOPOLAMINE-INDUCED NEUROCOGNITIVE DEFICITS VIA ACTIVATION OF Nrf2/HO-1 PATHWAY AND IMPROVED MITOCHONDRIAL ACTIVITY
Last updated: 09 Mar 2025
Article
Article
Article
Article
Article
Article
Article
Article
Article
Article